These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2889603)

  • 1. Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with sandostatin (SMS 201-995).
    Lamberts SW; Uitterlinden P; Verleun T
    Eur J Clin Invest; 1987 Aug; 17(4):354-9. PubMed ID: 2889603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years.
    Lamberts SW; Uitterlinden P; del Pozo E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):703-10. PubMed ID: 2888785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of acromegaly with sandostatin: the predictive value of an acute test, the value of serum somatomedin-C measurements in dose adjustment and the definition of a biochemical 'cure'.
    Lamberts SW; Uitterlinden P; Schuijff PC; Klijn JG
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):411-20. PubMed ID: 3251673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
    Barkan AL; Beitins IZ; Kelch RP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
    Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
    J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of SMS 201-995 in acromegaly.
    Lamberts SW; del Pozo E
    Scand J Gastroenterol Suppl; 1986; 119():141-8. PubMed ID: 2876498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term treatment of acromegaly with the somatostatin analog octreotide (Sandostatin). On the predictive significance of acute tests].
    Schmidt K; Althoff PH; Harris A; Hofmeister-Wagner W; Schifferdecker E; Schöffling K
    Med Klin (Munich); 1990 Dec; 85(12):700-6. PubMed ID: 2128367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion.
    Hunter SJ; Shaw JA; Lee KO; Wood PJ; Atkinson AB; Bevan JS
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):245-51. PubMed ID: 10396369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term management of acromegaly with sandostatin.
    Tolis G
    Horm Res; 1988; 29(2-3):112-4. PubMed ID: 2900189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatomedin-C levels in treated and untreated patients with acromegaly.
    Roelfsema F; Frölich M; Van Dulken H
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):137-44. PubMed ID: 3665113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response.
    Stonesifer LD; Jordan RM; Kohler PO
    J Clin Endocrinol Metab; 1981 Nov; 53(5):931-4. PubMed ID: 7197287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly.
    Barreca A; Ciccarelli E; Minuto F; Bruzzi P; Giordano G; Camanni F
    Acta Endocrinol (Copenh); 1989 May; 120(5):629-35. PubMed ID: 2728807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.
    Ho KY; Weissberger AJ; Marbach P; Lazarus L
    Ann Intern Med; 1990 Feb; 112(3):173-81. PubMed ID: 2404445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical effects of incremental doses of the long-acting somatostatin analogue SMS 201-995 in ten acromegalic patients.
    Shi YF; Harris AG; Zhu XF; Deng JY
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):695-705. PubMed ID: 2200620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.